Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1Phase 1/2 1Phase 1 1

Status

Not yet recruiting 2Completed 2Withdrawn 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 5

Conditions

Breast Neoplasms 10184Neoplasms 7810Carcinoma, Non-Small-Cell Lung 5760Prostatic Neoplasms 5024Colorectal Neoplasms 4606Lung Neoplasms 3725Leukemia, Myeloid, Acute 3102Neoplasm Metastasis 3083Multiple Myeloma 3082Pancreatic Neoplasms 2845Melanoma 2653Ovarian Neoplasms 2573Lymphoma 2571Carcinoma, Hepatocellular 2480Stomach Neoplasms 2330Recurrence 2230Head and Neck Neoplasms 2103Precursor Cell Lymphoblastic Leukemia-Lymphoma 2086Lymphoma, Non-Hodgkin 2058Leukemia 2013Brain Neoplasms 1905Glioblastoma 1797Colonic Neoplasms 1791Leukemia, Lymphocytic, Chronic, B-Cell 1771Rectal Neoplasms 1720Uterine Cervical Neoplasms 1693Squamous Cell Carcinoma of Head and Neck 1654Lymphoma, Follicular 1652Lymphoma, Large B-Cell, Diffuse 1597Carcinoma, Renal Cell 1577

Interventions

advexin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × Locally Advanced Breast Cancer (LABC) × Clear all
NCT07420335 2026-02-19

Preoperative Shoulder Exercises and Postoperative Inflammation, Pain, and Function After Modified Radical Mastectomy

Indonesia University

Phase NA Not yet recruiting
52 enrolled
Breast

Locally Advanced Breast Cancer (LABC)

NCT07150767 2025-12-02

A Clinical Study to Explore the Safety, Tolerability, and Efficacy of Recombinant Human nsIL12 Oncolytic Adenovirus Injection (BioTTT001) Combined With Neoadjuvant Treatment for Locally Advanced Breast Cancer

Beijing Bio-Targeting Therapeutics Technology Co., Ltd

Phase 1 Withdrawn
Breast

Locally Advanced Breast Cancer (LABC)

NCT07189884 2025-09-24

Pyrotinib Maleate Tablets in Combination With Dalpiciclib Isethionate Tablets and Standard Endocrine Therapy

The First Affiliated Hospital of Xiamen University

Phase 1/2 Not yet recruiting
33 enrolled
Breast

Locally Advanced Breast Cancer (LABC)

NCT01240681 2015-03-11

IMPACT

Ontario Clinical Oncology Group (OCOG)

Phase NA Completed
32 enrolled
Breast

Locally Advanced Breast Cancer (LABC)

NCT00286247 2008-04-01

Study to Determine the Efficacy and Safety of Docetaxel and Doxorubicin With INGN 201 in Locally Advanced Breast Cancer

Introgen Therapeutics

Phase 2 Completed
60 enrolled
Breast

Locally Advanced Breast Cancer (LABC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡